Long-Term Opportunity in Coca-Cola Despite Uncertainty
No one expected a stellar second quarter, but the beverage giant can overcome short-term weakness.
Investors were already expecting an ugly second quarter for wide-moat Coca-Cola (KO), so we think they were looking for details about margin dynamics, given the top-line pressure, and information about the speed of recovery in major markets. The results--a beat on the bottom line and in-line sales relative to CapIQ consensus--as well as management commentary, were mixed, but we remain optimistic about the firm’s ability to manage its business during the pandemic and about the overall health of the Coca-Cola system. As we tweak our short-term estimates after the earnings report, we do not plan to change our $54 fair value estimate, and while the firm’s near-term trajectory remains murky, we still see a meaningful long-term value proposition in the shares at current levels.
Revenue came in at $7.15 billion, a decline of over 28% from a year ago, 26% of which was organic. Most of the drop (22%) came from volume, with roughly half the result of business closures and shelter-in-place orders, and more modest declines in price/mix, as adverse channels/packages were partially offset by the underperformance of finished-goods businesses. The extent of lockdown orders and exposure to businesses that might remain closed remain the biggest short-term drivers, but the firm may have a hard time catching a break even as things return to normal. For example, in a region like Latin America, organic performance is being countervailed by currency weakness.
Segment dynamics were salient at the margin lines. Despite tremendous top-line weakness, adjusted operating margins proved quite resilient, contracting just 20 basis points to 30.1% as structurally higher-margin concentrate businesses increased within the mix. While brand investments will accelerate through the rest of the year, we still expect favorable segment mix to continue supporting profitability.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Nicholas Johnson does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.